Anaesthesia & intensive care medicine
Volume 10, Issue 2 , Pages 71-75 , February 2009

Transfusion principles in children

References 

  1. Health Service Circulars HSC 1998/224 and HSC 2002/009. Available from: http://www.doh.gov.uk/Publications
  2. McClelland , Contreras . Appropriateness and safety of blood transfusion. BMJ. 2005;330:104–105
  3. Gibson BE, Todd A, Roberts I, et al. Transfusion guidelines for neonates and older children. Br J Haematol. 2004;124:433–453
  4. Regan FA, Hewitt P, Barbara JA, et al. Prospective investigation of transfusion transmitted infection in recipients of over 20,000 units of blood. BMJ. 2000;320:403–406
  5. Snook NJ, O’Beirne HA, Enright S, et al. Use of recombinant human erythropoietin to facilitate liver transplantation in a Jehovah’s Witness. BJA. 1996;76:740–743
  6. Yassen KA, Bellamy MC, Sadek SA, et al. Transexamic acid reduces blood loss during orthotopic liver transplantation. Clin Transplant. 1993;7:453–458
  7. The Serious Hazards of Transfusion Steering Group . Serious hazards of transfusion annual report. Available from: http://www.shot-uk.org2006;
  8. Jackson E. Blood transfusion and conservation. In:  Bingham R,  Lloyd-Thomas A,  Sury M editor. Textbook of paediatric anaesthesia. 3rd edn.. Oxford: Oxford University Press; 2008;
  9. Joint UKBTS/NIBSC Professional Advisory Committee . Position statement. Estimates of the frequency of HBV, HCV, HIV and HTLV1 infectious donations entering the blood supply per million donations (and 1 per million donations) tested, UK. Available from: http://www.transfusionguidelines.org.uk2005–2006;
  10. Department of Health . Handbook of transfusion medicine. 4th edn.. London: The Stationery office; 2007;Available from: http://www.transfusionguidelines.org.uk
  11. Medicines and Healthcare products Regulatory Agency . Aprotinin (Trasylol): suspension of UK marketing authorisations (licences). Available from: http://www.mhra.gov.uk29 Nov 2007;
  12. Barcelona SL, Thompson AA, Cote CJ. Intraoperative pediatric blood transfusion therapy: a review of common issues. Part II. Transfusion therapy, special considerations and reduction of allogenic blood transfusions. Paediatr Anaesth. 2005;15:814–830
  13. Davies P, Robertson S, Hedge S, et al. Calculating the required transfusion volume in children. Transfusion. 2007;47:212–216
  14. Stainsby D, Maclennan S, Thomas D, et al. British Committee for Standards in Haematology: guidelines on the management of massive blood loss. Br J Haematol. 2006;135:634–641

PII: S1472-0299(08)00235-X

doi: 10.1016/j.mpaic.2008.10.002

Anaesthesia & intensive care medicine
Volume 10, Issue 2 , Pages 71-75 , February 2009

Article Tools